Clicky

Merck Kgaa Dm 5(MKGAF) News

Date Title
Oct 10 Merck unveils $318m biosafety testing facility in Maryland, US
Oct 10 MilliporeSigma invests $290m in biosafety facility in Maryland
Jul 24 Merck and GTRI to develop gene therapy for Parkinson’s disease
Jun 25 Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug
Jun 25 Merck KGgA shares slide after failure of potential head and neck cancer drug
Jun 23 Merck KGaA's (ETR:MRK) Stock Has Fared Decently: Is the Market Following Strong Financials?
May 15 Health Care Roundup: Market Talk
May 13 Lula’s progress plan for Brazil: A year on
Dec 8 Merck Navigates Chip Geopolitics With ‘China For China’ Strategy
Dec 6 Merck KGaA: MS drug failure is a sour note for growth hopes
Dec 6 German Merck’s MS drug falls short in pair of Phase 3 tests
Dec 6 Merck KGaA Plunges as Multiple Sclerosis Drug Fails in Trial
Dec 6 Merck MS Drug Fails to Meet Target of Late-Stage Trials
Dec 5 UPDATE 3-Merck KGaA suffers major blow as MS drug fails in late-stage trials
Nov 27 Merck KGaA's (ETR:MRK) Intrinsic Value Is Potentially 85% Above Its Share Price